An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Participants With Chronic Hepatitis C (CHC), Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy

NCT01416610 · clinicaltrials.gov ↗
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hoffmann-La Roche